International Stem Cell Corp. (OTCMKTS:ISCO – Get Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.14 and traded as high as $0.1681. International Stem Cell shares last traded at $0.1580, with a volume of 18,619 shares.
International Stem Cell Price Performance
The firm has a market capitalization of $1.26 million, a P/E ratio of -7.90 and a beta of 0.18. The company’s 50 day moving average price is $0.14 and its 200 day moving average price is $0.14.
About International Stem Cell
International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.
In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.
Recommended Stories
- Five stocks we like better than International Stem Cell
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- A U.S. “birthright” claim worth trillions – activated quietly
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
